Correlation Between Achilles Therapeutics and NextCure
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and NextCure, you can compare the effects of market volatilities on Achilles Therapeutics and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and NextCure.
Diversification Opportunities for Achilles Therapeutics and NextCure
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Achilles and NextCure is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and NextCure go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and NextCure
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.38 times more return on investment than NextCure. However, Achilles Therapeutics PLC is 2.63 times less risky than NextCure. It trades about 0.22 of its potential returns per unit of risk. NextCure is currently generating about -0.14 per unit of risk. If you would invest 98.00 in Achilles Therapeutics PLC on August 26, 2024 and sell it today you would earn a total of 8.00 from holding Achilles Therapeutics PLC or generate 8.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. NextCure
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| NextCure |
Achilles Therapeutics and NextCure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and NextCure
The main advantage of trading using opposite Achilles Therapeutics and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |